PEOPLE - Changes at Adaltis:
This article was originally published in Clinica
Adaltis (Montreal, Quebec) has appointed Jacques Deforges as vice-president of finance and CFO, and Keith Flavell as vice-president, legal affairs and corporate secretary. Adaltis develops, manufactures and markets diagnostic systems and reagent products for viral infections, immune system diseases and human hormone responses.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.